Comparison of IOP spikes with two ophthalmic viscosurgical devices following Visian ICL(V4C model) insertion in the immediate post operative period

ethradhama Eye Hospital0 个研究点目标入组 15 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of any gender, between the age group of 21 to 45 years, undergoing ICL surgery with
•V4C (Centraflow) model for correction of Myopic refractive error including myopic astigmatism
•(of any degree) will be included in the trial.
•1.Adequate AC depth ( >2.8 mm from endothelium)
•2.Healthy eyes besides myopic refractive error (of any degree amenable to correction with Visian ICL, Centraflow)
•3. Stable refraction and corneal conditions within the last 12 months
•4.Signed informed consent , willingness to participate in trial and subsequent follow ups

•Glaucoma or IOP higher than 24mmHg
•Posterior segment disorders (e.g. Retinal degenerations , macular pathology, optic nerve atrophy, hereditary retinal disorders)
•Pseudophakia/ Aphakia
•Corneal dystrophies / corneal degenerations /Corneal scarring
•Irregular astigmatism (e.g. Keratoconus, Pallucid Marginal Degeneration etc)
•Post corneal refractive surgery
•Moderate to severe dry eye, Severe Contact lens induced ocular allergy
•Congenital ocular anomalies â?? Aniridia/ Iris coloboma, microcornea, nanophthalmos
•Pseudoexfoliation Syndrome; Uveitis
•Prior use of long term antiglaucoma or steroid medications

发起方

ethradhama Eye Hospital